Skip to main content
. Author manuscript; available in PMC: 2009 Dec 15.
Published in final edited form as: Cancer Res. 2008 Dec 15;68(24):10205–10214. doi: 10.1158/0008-5472.CAN-08-2149
Vimentin: forward 5′- ATTCCACTTTGCGTTCAAGG -3′, reverse 5′- CTTCAGAGAGAGGAAGCCGA -3′
CD44: forward 5′-CCATCTGTGCAGCAAACAAC- 3′, reverse 5′-GAGCTGAAGCATTGAAGCAA -3′
Wnt5A: forward 5′-TAAGCCCAGGAGTTGCTTTG- 3′, reverse 5′-GCAGAGAGGCTGTGCTCCTA-3′
MART-1: forward 5′-AGAAGATGCCCACAAGAAGG- 3′, reverse 5′-CGCTGGCTCTTAAGGTGAAT-3′
SOX10: forward 5′-AAAGACCACCCGGACTACAA- 3′, reverse 5′-TTGCCGAAGTCGATGTGA-3′
IL-6R: forward 5′-GGGACCATGGAGTGGTAGC- 3′, reverse 5′-ACTGGTCAGCACGCCTCT-3′.